07:00 , Jul 23, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Stearoyl-CoA desaturase-1 (SCD1)

Cancer INDICATION: Cancer; diabetes; obesity In vitro and mouse studies suggest inhibiting SCD1 could help treat cancer, diabetes and obesity. Dysregulated sirtuin 1 (SIRT1) expression has been implicated in metabolic disorders and cancers. In mice,...
07:00 , Jul 9, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Deleted in breast cancer 1 (DBC1; CCAR2); forkhead box P3 (FOXP3)

Cancer INDICATION: Autoimmune disease In vitro and mouse studies suggest inhibiting DBC1 could help treat autoimmune diseases. In vitro studies identified DBC1 as a binding partner of FOXP3 , a Treg cell marker. In normal...